WallStSmart
GYRE

Gyre Therapeutics Inc.

NASDAQ: GYRE · HEALTHCARE · BIOTECHNOLOGY

$7.68
+4.49% today

Updated 2026-04-30

Market cap
$696.73M
P/E ratio
381.50
P/S ratio
5.98x
EPS (TTM)
$0.02
Dividend yield
52W range
$7 – $12
Volume
0.1M

Gyre Therapeutics Inc. (GYRE) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$27.54M$11.58M$20.09M$25.06M$85.71M$97.64M$57.86M$3.63M$275000.00$1.75M$399000.00$1.02M$6000.00$20.95M$7.34M$102.29M$113.45M$105.76M$116.59M
Revenue growth (YoY)-58.0%+73.5%+24.8%+242.0%+13.9%-40.7%-93.7%-92.4%+536.4%-77.2%+155.1%-99.4%-100.0%-65.0%+1294.0%+10.9%-6.8%+10.2%
Cost of revenue$457254.00$715424.00$749000.00$691000.00$6.56M$5.27M$5.96M$10.55M$12.85M$21.47M$146000.00$9.16M$7.67M$4.79M$4.64M$3.88M$5.42M
Gross profit$27.08M$10.86M$19.34M$24.37M$85.71M$97.64M$57.86M$-2.93M$-4.99M$-4.21M$-10.16M$-11.83M$-21.47M$-146000.00$11.79M$-332000.00$97.50M$108.81M$101.87M$111.17M
Gross margin98.3%93.8%96.3%97.2%100.0%100.0%100.0%-80.7%-1815.3%-240.5%-2545.4%-1162.0%-357800.0%56.3%-4.5%95.3%95.9%96.3%95.4%
R&D$21.79M$34.62M$40.98M$40.18M$64.55M$95.22M$49.09M$38.84M$19.50M$5.96M$11.55M$12.85M$21.47M$43.86M$52.98M$64.57M$16.69M$13.78M$12.02M$13.70M
SG&A$5.70B$8.01B$6.50M$8.17M$8.05M$12.17M$13.19M$12.01M$10.17M$9.59M$9.26M$9.99M$12.35M$13.42M$16.18M$18.82M$17.37M$14.66M$16.11M$20.80M
Operating income$-403692.00$-31.77M$-28.14M$-40.33M$13.12M$-9.74M$-8.14M$-47.22M$-29.71M$-13.80M$-20.42M$-21.82M$-33.82M$-57.28M$-57.37M$-83.73M$9.20M$-67.23M$16.16M$11.49M
Operating margin-1.5%-274.5%-140.1%-160.9%15.3%-10.0%-14.1%-1301.1%-10805.1%-788.7%-5117.3%-2143.6%-563700.0%-273.9%-1141.0%9.0%-59.3%15.3%9.9%
EBITDA$417228.00$-30.86M$-28.14M$-40.33M$13.12M$-9.74M$-8.14M$-47.22M$-29.71M$-12.81M$-16.95M$-21.82M$-33.82M$-55.03M$-56.10M$-87.64M$10.33M$20.33M$17.82M$14.01M
EBITDA margin1.5%-266.6%-140.1%-160.9%15.3%-10.0%-14.1%-1301.1%-10805.1%-732.2%-4246.9%-2143.6%-563700.0%-267.8%-1194.4%10.1%17.9%16.8%12.0%
EBIT$-403692.00$-31.77M$-29.94M$-42.16M$11.12M$-12.22M$-10.35M$-47.76M$-30.07M$-13.28M$-17.33M$-22.00M$-33.97M$-55.18M$-56.24M$-87.93M$9.20M$19.21M$16.23M$11.49M
Interest expense$84.07M$137.91M$251000.00$217000.00$153000.00$132000.00$86000.00$53000.00$23000.00$1.48M$220958.00$717000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$2.10M$-28.07M$-25.66M$-39.40M$10.90M$-8.53M$-7.00M$-46.70M$-32.62M$-14.76M$-16.95M$-21.56M$-30.05M$-55.18M$-55.54M$-87.93M$2.30M$-92.93M$12.09M$5.03M
Net income growth (YoY)-1439.0%+8.6%-53.6%+127.7%-178.3%+18.0%-567.4%+30.2%+54.7%-14.8%-27.2%-39.4%-83.6%-0.7%-58.3%+102.6%-4137.1%+113.0%-58.4%
Profit margin7.6%-242.5%-127.8%-157.2%12.7%-8.7%-12.1%-1287.0%-11862.9%-843.5%-4246.9%-2118.0%-500916.7%-265.1%-1198.3%2.3%-81.9%11.4%4.3%